Suppr超能文献

经皮胆道引流术后恶性胆道梗阻患者功能性引流与生存的相关性

Correlation between functional drainage and survival in malignant biliary obstruction after percutaneous biliary drainage.

作者信息

Yang Hongzhi, Qin Qiujian, Tang Yulin, Zhu Wenliang

机构信息

Department of General Surgery, Minzu Hospital of Guangxi Zhuang Autonomous Region, No 232 Mingxiudong Road, Nanning 531200, China.

General Surgery, People's Hospital of Laibin, No 159 PanGu Road, Laibin, Guangxi, 546100, China.

出版信息

Heliyon. 2024 Jan 8;10(2):e24088. doi: 10.1016/j.heliyon.2024.e24088. eCollection 2024 Jan 30.

Abstract

PURPOSE

Malignant biliary obstruction (MBO) is common in patients with advanced malignant tumors, leading to poor prognosis and hindering antitumor therapy. The purpose of our study was to assess the survival outcomes for patients under therapy after percutaneous transhepatic biliary drainage (PTBD) and identify prognostic factors associated with survival in patients with MBO.

METHODS

From July 2010 to February 2021, 269 patients with MBO secondary to malignant tumor were divided into two groups (functional success and non-functional success). Survival time and prognostic factors were analyzed by Kaplan-Meier curves and the Cox model.

RESULTS

The overall median survival time after PTBD was 4.6 months (95 % IC:3.9-5.3). The 3- and 6-month survival rates were 68.0 % and 38.7 %, respectively. The median survival improved from 3.2 months to 8.4 months when the procedure achieved functional success. Multivariate analysis demonstrated that functionally successful drainage and antitumor treatment after PTBD were independent positive prognostic factors, but the total bilirubin after drainage and tumor size were independent negative predictive values.

CONCLUSIONS

Functionally successful drainage could prolong survival time in patients with malignant biliary obstruction. Palliative care after drainage can prolong patient survival and improve their quality of life.

摘要

目的

恶性胆管梗阻(MBO)在晚期恶性肿瘤患者中很常见,导致预后不良并阻碍抗肿瘤治疗。我们研究的目的是评估经皮经肝胆道引流(PTBD)治疗后患者的生存结局,并确定与MBO患者生存相关的预后因素。

方法

2010年7月至2021年2月,269例继发于恶性肿瘤的MBO患者被分为两组(功能成功组和功能未成功组)。通过Kaplan-Meier曲线和Cox模型分析生存时间和预后因素。

结果

PTBD后的总体中位生存时间为4.6个月(95%置信区间:3.9 - 5.3)。3个月和6个月的生存率分别为68.0%和38.7%。当该操作取得功能成功时,中位生存时间从3.2个月提高到8.4个月。多因素分析表明,PTBD后功能成功的引流和抗肿瘤治疗是独立的阳性预后因素,但引流后的总胆红素和肿瘤大小是独立的阴性预测指标。

结论

功能成功的引流可延长恶性胆管梗阻患者的生存时间。引流后的姑息治疗可延长患者生存期并改善其生活质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/778d/10826644/8ac16464bf08/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验